S

Sonoma Pharmaceuticals
D

SNOA

2.98000
USD
0.13
(4.56%)
Market Closed
Volume
887
EPS
-4
Div Yield
-
P/E
-3
Market Cap
3,990,727
OverviewSignalsIdeasNews
Related Instruments
    AZN
    AZN
    -1.830
    (-2.81%)
    66.385 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.76 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    754.1 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    101.205 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    103.54 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    26.16 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    More
News

Title: Sonoma Pharmaceuticals Inc

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.